Crossmark

Evaluation of the performance of Fe3O4/MnO2@doxorubicin hybrid nanozymes on multicellular structure and their therapeutic management to limit the growth of human breast cancer cells

Crossref DOI link: https://doi.org/10.1186/s12645-024-00293-z

Published Online: 2024-09-28

Published Print: 2024-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Sharifi, Majid

Kamalabadi-Farahani, Mohammad

Salmani, Amir-Abas

Malaki, Mahmoud
License Information

Text and Data Mining valid from 2024-09-28

Version of Record valid from 2024-09-28
More Information

Article History

Received: 14 May 2024

Accepted: 18 September 2024

First Online: 28 September 2024

Declarations

:

: All authors read and approve the final manuscript.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below